Stephen J. Iacoboni

TOPIC-The inflated Cost Of Cancer Treatment

Stephen J. Iacoboni, MD., Oncologist, Care Advocate, Author

Cancer treatment is big business. Cancer care ads comfort us and the big drug companies advertise their new products.

Behind the scene is the fact that less profitable-but-effective, generic cancer drugs are under produced … and the reason is MONEY!!!

A generic drug sells for $50-$100 per dose, and a new drug sells for $2,000-$3,000 per dose, …. you do the math … they sure did!

Facing Cancer treatment is a difficult task made all the worse by gruesome side effects. While encouraged by today’s news of stem cell technology shielding side effects, the unnecessary shortage of effective Chemotherapy drugs drives costs up and patient care down.

Stephen J. Iacoboni, MD., Oncologist, Care Advocate, Author
On TV and radio across the US, He is telling the truth about cancer and the shortage of affordable cancer drugs. Disclosing the facts, Dr. Iacoboni uncovers the bad economics, dirty politics and corporate greed that affect patients’, health care and world-wide health costs.

Dr. Iacoboni served his fellowship in medical oncology at the MD Anderson Cancer Center in Houston where he received the outstanding researcher award and was honored to present his research findings at the American Society of Clinical Oncology. In 1989 Dr. Iacoboni co-founded St. Mary’s Regional Cancer Center in Walla Walla Washington, where he lived and practiced for 16 years. He accepted the position of Medical Director at the Kootenai Cancer Center in Coeur d’Alene, Idaho in 2001, and in 2010 returned to Washington to co-direct the Kennewick General Hospital Hematology-Oncology program. His book, The Undying Soul- A Cancer Doctor’s Discovery is a powerful journey enabling doctor and patient to walk the hard road from the failure of science to the triumph of spirit.

Date Recorded: 8/7/2012

Podcast of the interview Download:
 

• Tweet
• Pin It